An update on methotrexate pharmacogenetics in rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

http://www.wikidata.org/entity/Q37126658

about

Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction Treatment of acute lymphoblastic leukemia from traditional chinese medicine Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study.Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.Rheumatoid arthritis pharmacogenomics.Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.Pharmacogenetics and immunosuppressive drugs.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Pharmacogenetics of inflammatory bowel disease.Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.

P2860

Q27023839-276E2B79-6D98-4559-994A-F94D3973F706 Q33746550-1979A2C3-79B4-4EA6-9249-ABD131892A8F Q34559803-1FB7B9F8-9CE3-4867-B904-D45E563DFC90 Q34807469-0A937813-2846-41AE-8B63-0B53A7112B00 Q35092982-1F642418-8E70-4988-A3DE-87F654954714 Q36109604-209CD8E3-6EE2-4407-B077-B024395018AA Q37158455-1748DDD1-827F-41E6-B7F0-2F5ADA29F3E9 Q37491021-4EB97921-05C7-4EC4-9AEA-F1970C955A62 Q37587400-576FA3DD-1EF7-4D66-AD4B-7D52D9900915 Q37683906-198D70D3-229C-4F14-BB43-3815CBA5E156 Q37725354-F774DC22-2379-4C90-968F-C7F5404FC033 Q37736447-25229CA4-4D7C-4998-9E1C-BCF5EAF141AB Q38022258-222DF83A-1BA8-4827-AD5F-11944AB53720 Q38080147-E16606EA-9C86-44DA-B133-3BFCC47EFF40 Q38084444-8F40C3B7-402B-4A62-8DD4-8E7CFD513921 Q38195630-DCD42BF8-7363-49D6-935E-4B5A7C27D089 Q38258677-98D979A4-9909-4840-B065-D5AE79566118 Q38501680-FB4F0F99-CBD2-40F4-8409-E7EE4BD3B2FC Q41673937-91B72C15-4EDA-47C0-BDAE-1C0257592E84 Q41714062-98904410-9F28-4E61-872E-BEB234416326

P2860

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

http://www.wikidata.org/entity/Q37126658

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

@en

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

@nl

type

label

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

@en

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

@nl

prefLabel

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

@en

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

@nl

P1433

Q37126658-33F9B724-5365-4E7D-ABCD-4D918FE49D5F

P1476

Q37126658-0B9A1F9E-B618-4EF1-B0EB-CFE38BE7EBD3

P2093

Q37126658-9056FCE3-0112-4E71-8EBA-8D5FA10DEAF7

P2860

Q37126658-01BC3E55-C43B-40D6-B45B-FEDC11810875

Q37126658-09940D98-91A9-407F-9616-46EC714E06BE

Q37126658-11B493FD-AE2C-4F92-8A1C-7CA95A8E155F

Q37126658-16727295-B77D-41A5-A184-05169D707E1A

Q37126658-1D42316D-74CB-4356-86FB-020AE1A8A230

Q37126658-26CAFCCE-0995-4122-BEC1-C911A0F26CC8

Q37126658-2CFFD76E-A4FE-4F2D-8A44-2702418031B1

Q37126658-3549E275-7D81-4F3A-9BD3-7246061F6631

Q37126658-42A7F6CA-9480-4832-AF46-D34C210502B4

Q37126658-5AB1CEFA-5EA5-418C-B204-908A347B199C

P304

Q37126658-88CADF56-7A29-41DA-AC5A-A049A633625E

P31

Q37126658-2820E701-8020-4BD5-B31C-EB9BD9E7F2EF

P356

Q37126658-47048AE1-9FAA-489F-9498-AD57B20E1E72

P433

Q37126658-8FE6B2AD-B929-4614-B97E-49D52D5CCF9B

P478

Q37126658-617530AE-29C2-4FA7-9C7D-E456B936C614

P577

Q37126658-80FBF181-6491-45D3-BD30-882F1210395C

P698

Q37126658-092A9601-3818-432F-82F5-F467FA5F0C1F

P356

14622416.9.4.439

P1433

Pharmacogenomics

P1476

An update on methotrexate pharmacogenetics in rheumatoid arthritis.

@en

P2093

Prabha Ranganathan

http://www.w3.org/2001/XMLSchema#string

P2860

Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders

Molecular action of methotrexate in inflammatory diseases

A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defec

MRP3, an organic anion transporter able to transport anti-cancer drugs

A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida

Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction

Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

P304

439-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.9.4.439

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18384257

http://www.w3.org/2001/XMLSchema#string